A review of the evidence strongly supports routine utilization of statins as adjuvant pharmacological therapy before percutaneous coronary revascularization. Therapeutic Advances in Cardiovascular Disease
A cohort study confirmed high risks for symptomatic venous and arterial thromboembolic events in patients with nephrotic syndrome, especially in the first 6 months, and identified predictors of risk. Medscape Medical News
Intravenous iron dextran is widely used in hemodialysis patients receiving erythropoietin therapy, but how much of it is removed during hemodialysis? Transfusion Alternatives in Transfusion Medicine
Biomarkers can be used to predict both the incidence and severity of disease, but the use of these markers for acute kidney injury is limited. The current review examines the status of biomarkers for acute kidney injury. Nature Clinical Practice Nephrology